Protein S100-A10

BE0009033ProteinHumansS100A10

Because S100A10 induces the dimerization of ANXA2/p36, it may function as a regulator of protein phosphorylation in that the ANXA2 monomer is the preferred target (in vitro) of tyrosine-specific kinase. It is acted on by 1 drug in DrugBank.

Gene name
S100A10
UniProtKB entry
P60903Swiss-Prot
Residues / weight
97 residues · 11,203 Da
Also known as
ANX2LG · CAL1L · Calpactin I light chain · Calpactin-1 light chain · Cellular ligand of annexin II

Resolves to

Protein
UniProtP60903UniProt nameS10AA_HUMAN
Gene
HGNCHGNC:10487NCBI Gene6281GeneCardsS100A10
Pharmacology
KEGGhsa:6281
Structure
PDB1A4PPDB1BT6PDB4DRW
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
19GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
12+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Protein S100-A10, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In